Olema CFO Exit Puts Focus On Palazestrant Plans And Cash Discipline [Yahoo! Finance]
Olema Pharmaceuticals, Inc. (OLMA)
Company Research
Source: Yahoo! Finance
Olema Pharmaceuticals (NasdaqGS:OLMA) announced the departure of Chief Operating and Financial Officer Shane Kovacs. Kovacs will continue to support the company as a consultant during the transition period. Chief Executive Officer Dr. Sean P. Bohen will serve as interim Principal Financial Officer. For investors watching Olema Pharmaceuticals at a share price of $25.72, this leadership change follows a very large 1-year return and a 3-year return of about 7x. Over the past month, the stock shows a 2.9% return and a value score of 3, which may help readers frame this governance shift against recent share performance. Leadership transitions in key financial roles can influence how investors think about oversight, reporting quality, and the company's ability to execute on its plans. With Kovacs remaining as a consultant and Dr. Bohen stepping in, the coming quarters may help clarify how smoothly Olema aligns its operational and financial decision making under this new structure.
Show less
Read more
Impact Snapshot
Event Time:
OLMA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OLMA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OLMA alerts
High impacting Olema Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
OLMA
News
- Olema Oncology to Participate in Upcoming Investor ConferencesGlobeNewswire
- Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- LifeSci Capital Reiterates a Buy on Olema Pharmaceuticals (OLMA) [Yahoo! Finance]Yahoo! Finance
- Olema Oncology Announces Departure of Chief Operating and Financial OfficerGlobeNewswire
- JPM26: Roche's rejuvenation strategy for the oncology and haematology portfolio [Yahoo! Finance]Yahoo! Finance
OLMA
Earnings
- 11/10/25 - Miss
OLMA
Sec Filings
- 2/5/26 - Form SCHEDULE
- 2/4/26 - Form 4
- 2/4/26 - Form 4
- OLMA's page on the SEC website